Skip to main content
Have a personal or library account? Click to login
HIV Encephalopathy in Perinatally Acquired Disease Cover

HIV Encephalopathy in Perinatally Acquired Disease

Open Access
|Jun 1998

Full Article

The incidence and clinical progression of HIV encephalopathy among 128 HIV-perinatally infected children were studied at multiple US centers by the Women and Infants Transmission Study Group. During a median follow-up of 24 months, HIV encephalopathy was diagnosed in 27 (21%), with a median survival of 14 months and a mortality rate of 41%. In the encephalopathy cases, immunosuppression was present in 20 (74%), hepatosplenomegaly or lymphadenopathy in 63%, and cardiomyopathy in 30%. Failure to gain weight predated the onset of encephalopathy in infected infants. HIV infected children without encephalopathy had a lower incidence of hepatosplenomegaly (29%) and cardiomyopathy (2%), diagnosed in the first 3 months of life. Risk of encephalopathy was related to a high viral load in infancy. [1]

COMMENT. Encephalopathy is a frequent complication of perinatally acquired HIV infection, occurring in one in 5 infants. A high viral load during the neonatal period, failure to thrive, and early signs of organomegaly and lymphadenopathy are risk factors for HIV encephalopathy.

Language: English
Page range: 44 - 45
Published on: Jun 1, 1998
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 1998 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.